Carisma Therapeutics to Present at Upcoming Conferences

2024-04-03

免疫疗法细胞疗法

PHILADELPHIA, April 3, 2024 /PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a clinical-stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced that it will present at the following upcoming conferences:

Needham 23rd Annual Virtual Healthcare Conference

Steven Kelly, President and Chief Executive Officer, will give a corporate presentation.

Wednesday, April 10 at 3:45 PM ET

Virtual

Chardan 8th Annual Genetic Medicines & Cell Therapy Manufacturing Summit

Steven Kelly, President and Chief Executive Officer, will give a corporate presentation.

Monday, April 29 at 2:00 PM ET

Virtual

Live webcasts will be available on the Company's Investor Events webpage. A replay of the webcasts, when available, will be archived for a limited time following each event.

About Carisma

Carisma Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on utilizing our proprietary macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. We have created a comprehensive, differentiated proprietary cell therapy platform focused on engineered macrophages and monocytes, cells that play a crucial role in both the innate and adaptive immune response. Carisma is headquartered in Philadelphia, PA. For more information, please visit www.carismatx.com.

Investors:

Shveta Dighe

Head of Investor Relations

[email protected]

Media Contact:

Julia Stern

(763) 350-5223

[email protected]

SOURCE Carisma Therapeutics Inc.

更多内容，请访问原始网站

文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。

机构